What is Xeroderma Pigmentosum (XP)?
A rare autosomal recessive disorder characterized by extreme sensitivity to UV light, leading to a high incidence of skin cancers and frequently, neurological abnormalities.
What is the fundamental molecular defect in XP?
A defect in Nucleotide Excision Repair (NER), specifically in the pathway that removes bulky DNA lesions like pyrimidine dimers caused by UV radiation.
What is the clinical hallmark of XP?
Severe sunburn reaction, freckling on minimal sun exposure, dry skin (xeroderma), and pigmentary changes, leading to skin cancers (BCC, SCC, melanoma) at a very young age.
How is XP genetically classified?
Into 7 complementation groups (XP-A through XP-G) based on the defective gene, plus a variant type (XP-V). Each group corresponds to a mutation in a different protein involved in NER.
What is the specific defect in the variant form, XP-V?
XP-V is not a classic NER defect. It is caused by a mutation in DNA polymerase η, a transfusion synthesis polymerase that correctly bypasses UV-induced thymine dimers.
What is the consequence of the defective NER machinery?
UV-induced DNA damage (like thymine dimers) accumulates and is not repaired. This leads to an increased mutation rate during DNA replication, which ultimately causes skin cancer.
Why do some XP patients develop neurological symptoms?
The defective NER proteins are also involved in repairing oxidative DNA damage in neurons. Their deficiency leads to progressive neuronal death, causing symptoms like sensorineural deafness and ataxia.
What is the primary medical management for XP?
Rigorous, lifelong protection from UV radiation: avoiding sunlight, using protective clothing, and applying high-SPF sunscreen.
Which DNA repair pathway is defective in classic XP groups (A-G)?
The Nucleotide Excision Repair (NER) pathway.
What type of DNA lesions does NER primarily target?
Bulky, helix-distorting lesions, such as pyrimidine dimers (from UV) and large chemical adducts.